KCNJ10 and Parkinson disease: This was confirmed by quantification of oligomeric α-syn/ Kir4.1 co-localization, which was elevated in cortex, corpus striatum, midbrain and cerebellum of mice injected with Parkinson’s disease compared to control RBC-EVs (Fig. 4b).